Mental Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
University of Freiburg
Reports add new data to stroke research
December 17th, 2005
Data on stroke are outlined in reports from Germany, Japan and the United States. Study 1: Oral atorvastatin treatment has long-term protective effects in an in vivo stroke model. "Statins exert beneficial effects in brain diseases including stroke," according to researchers in Germany, who "investigated whether oral prophylactic atorvastatin provides long-term neuroprotection and functional recovery in permanent middle cerebral artery occlusion (pMCAO), and whether cerebral hemodynamics are affected." In this study, "male Long-Evans rats were treated with 10 mg/kg oral atorvastatin for 14 days and subjected to pMCAO," explained...
Source: Mental Health Law Weekly (2005-12-17)
|
